C

CorMedix
D

CRMD

10.570
USD
-0.16
(-1.49%)
مغلق
حجم التداول
0
الربح لكل سهم
2
العائد الربحي
-
P/E
14
حجم السوق
825,080,522
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ سنة
buy
2024-10-03 07:52
CRMD Chart
المزيد
أصول ذات صلة الأخبار المقالات

العنوان: CorMedix

القطاع: Healthcare
الصناعة: Biotechnology
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.